Inventor
BRENNEMAN DOUGLAS E
US14 patents
⚠️ This page may combine multiple inventors who share the name “BRENNEMAN DOUGLAS E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
6 patentsUS5767240AJun 16, 1998
Activity-dependent neurotrophic factor
US HEALTH33 citations92
US7264947B2Sep 4, 2007
Activity dependent neurotrophic factor III (ADNF III)
US HEALTH26 citations91
US7384908B1Jun 10, 2008
Orally active peptides that prevent cell damage and death
US HEALTH17 citations90
US6649411B2Nov 18, 2003
Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides
US HEALTH22 citations90
US5217953AJun 8, 1993
Vasoactive intestinal peptide antagonist
US HEALTH30 citations89
US7427590B2Sep 23, 2008
Neurothrophic components of the ADNF I complex
US HEALTH15 citations80
UNIV RAMOT
5 patentsUS6613740B1Sep 2, 2003
Activity dependent neurotrophic factor III (ADNF III)
UNIV RAMOT49 citations95
US6174862B1Jan 16, 2001
Neurotrophic peptides of activity dependent neurotrophic factor
UNIV RAMOT46 citations92
US7863247B1Jan 4, 2011
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
UNIV RAMOT17 citations91
US6933277B2Aug 23, 2005
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
UNIV RAMOT28 citations91
US5565424AOct 15, 1996
Superactive VIP antagonists
UNIV RAMOT29 citations91